Chemotherapy with DMXAA (5,6-dimethylxanthenone-4-acetic acid) in combination with CI-1010 (1H-imidazole-1-ethanol, α-[[(2-bromoethyl)amino]methyl]-2-nitro-, mono-hydrobromide (R isomer)) against advanced stage murine colon carcinoma 26

Oncology Reports

Volumn 4, Issue 1, 1997, Pages 143-147

  Vincent, Patrick W ^a  

^a PFIZER INC   (United States)

Author keywords

DMXAA; Hypoxia; In vivo; Radiosensitizer

Indexed keywords

1 (2 BROMOETHYLAMINO) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031017640     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Chaplin DJ, Olive PL and Durand RE: Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 47: 597-601, 1987.
2. Siemann DW: Keynote address: tissue oxygen manipulation and tumor blood flow. Int J Radiat Oncol Biol Phys 22: 393-395, 1991.